The Journal

Peptide Therapy Insights

Evidence-based guides, regulatory updates, and expert perspectives on peptide therapy. Stay informed with the latest research and clinical insights.

More in Regulatory

Regulatory

Is AHK-Cu Legal? FDA Status and Regulations Explained (2026)

Explore the regulatory landscape of AHK-Cu, including its FDA status, compounding legality, and what patients need to know about this research peptide.

Feb 17, 2026Read article

Regulatory

The FDA and Peptides: What's Legal, What's Banned, and What's in Between (2026 Update)

FDA peptide regulations 2026: 503A/503B, Category 1 vs prohibited, January 2025 guidance, which peptides can be compounded, and enforcement.

Feb 11, 2026Read article

Regulatory

BPC-157: Benefits, Risks, and Legal Status Explained

BPC-157 benefits, risks, and legal status: what it is, claimed benefits, animal data, FDA Category 2, DOJ enforcement, and legal alternatives.

Feb 9, 2026Read article

Stay Up to Date

New articles on peptide therapy, FDA regulations, and clinic reviews are published regularly. Bookmark this page or check back often.

Find a Clinic Peptide Encyclopedia